BP000149-C416: Recombinant Human Interleukin-24 (IL-24) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000163-C030: Recombinant Human Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in NIH-3T3 cells was found to be approximately 10 ug/ml, corresponding to a Specific Activity of 1.0 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000163-CA22: Recombinant Human Interleukin-17F (IL-17F) Protein
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000149-CYT-515: Recombinant Human Interleukin-24 (IL-24) Protein
Source: E. coli-derived.
Measured by its ability to bind to the cell receptor of Capan-1 cells line resulted in Stat-3 activation. The ED50 for this effect is typically 1 ug/ml corresponding to a Specific Activity of 1 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000163-CYT-103: Recombinant Human Interleukin-17F (IL-17F), HEK Protein
Source: HEK-derived.
The specific activity was determined by the dose-dependent induction of IL-6 secretion from NHDF Adult fibroblasts, and is typically 100-500 ug/ml.
Purity: > 95% by SDS-PAGE.BP000163-CYT-587: Recombinant Human Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000163-CYT-642: Recombinant Mouse Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000163-CYT-643: Recombinant Rat Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.